Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Horizon Therapeutics (NQ: HZNP )

115.70 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Horizon Therapeutics

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Horizon Therapeutics' Debt Overview
Via Benzinga
7 Over-$100 Stocks That Are Worth Every Penny
To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources... 
Via Benzinga
Nearly One-Third of Billionaire George Soros' Portfolio Is Invested in These 10 Stocks
One of Soros' top 10 holdings looks especially attractive right now. 
Via The Motley Fool
Amgen Sinks On Mixed Earnings As 2023 Guidance Comes Up Short
Amgen reported lighter-than-expected earnings, but sales beat forecasts. 
Via Investor's Business Daily
Horizon Therapeutics Touts Positive Data From Mid-Stage Study For Immune System Disorder
Via Benzinga
$1000 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock
Two well-regarded billionaire investors -- George Soros and Paul Tudor Jones -- bought Horizon (HZNP) stock last quarter. 
Via InvestorPlace
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
Billionaire-led investing firms scooped up shares of Paramount Global, Bank of America, and Horizon Therapeutics in Q4. 
Via The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
The major indexes continued to run despite mixed-to-weak earnings. 
Via Investor's Business Daily
$100 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Bullish Sign Appears On Horizon Therapeutics's Chart
Via Benzinga
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
Via Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Via Benzinga
3 Biotech Companies to Watch in 2023
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year. 
Via InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
5 Most Expensive Health Care Stocks You Should Worry About
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while. 
Via The Motley Fool
How Did 2022’s Most Loved Stocks By Analysts Fare?
Looking at just stocks with coverage from at least eight analysts, the average Russell 1,000 stock had about 59% buy ratings at the start of 2022. 
Via Talk Markets
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Analyzing Horizon Therapeutics's Short Interest
Horizon Therapeutics's (NASDAQ:HZNP) short percent of float has fallen 7.07% since its last report. The company recently reported that it has 6.49 million shares sold short, which is 2.89% of all... 
Via Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
Vertex Therapeutics and Amgen have the building blocks for long-term success. 
Via The Motley Fool
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
Even if interest rates go up, you likely won't need to worry about these stocks. 
Via The Motley Fool
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Moderna spiked on a cancer vaccine while Tesla continued to dive. 
Via Investor's Business Daily
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
Prominent market commentator Jim Cramer said three corporate deals announced on Monday aided the rally seen at the beginning of the week,  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.